Completed PHASE4 INTERVENTIONAL 3-arm NCT01889758

Pharmacokinetic Studies of Tacrolimus in Transplant Patients (PK)

Sponsor: Children's Hospital Medical Center, Cincinnati

Conditions Kidney Transplant Recipients Liver Transplant Recipients

Updated 6 times since 2017 Last updated: Feb 19, 2016 Started: Jun 30, 2013 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Kidney Transplant Recipients and Liver Transplant Recipients, this trial is completed. The trial is conducted by Children's Hospital Medical Center, Cincinnati and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital Medical Center, Cincinnati
University of Cincinnati
University of Colorado, Denver

Data source: University of Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States